NO308107B1 - Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel - Google Patents

Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel

Info

Publication number: NO308107B1
Authority: NO; Norway
Prior art keywords: compound; preparation; formulation containing; pharmaceutical; unsolvated crystalline
Prior art date: 1994-09-19

Application number

NO953657A

Other languages

English (en)

Norwegian (no)

Other versions

NO953657D0 (no

NO953657L (no

Inventor

Elizabeth Smith Labell

Wayne Douglas Luke

Iii John Mcneill Mcgill

Randal Scot Miller

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-19

Filing date

1995-09-15

Publication date

2000-07-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26976194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO308107(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-09-19 Priority claimed from US08/308,325 external-priority patent/US5629425A/en

1995-09-15 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1995-09-15 Publication of NO953657D0 publication Critical patent/NO953657D0/no

1996-03-20 Publication of NO953657L publication Critical patent/NO953657L/no

2000-07-24 Publication of NO308107B1 publication Critical patent/NO308107B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO953657A 1994-09-19 1995-09-15 Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel NO308107B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/308,325 US5629425A (en)	1994-09-19	1994-09-19	Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
US42791495A	1995-04-26	1995-04-26

Publications (3)

Publication Number	Publication Date
NO953657D0 NO953657D0 (no)	1995-09-15
NO953657L NO953657L (no)	1996-03-20
NO308107B1 true NO308107B1 (no)	2000-07-24

Family

ID=26976194

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO953657A NO308107B1 (no)	1994-09-19	1995-09-15	Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel
NO19953658A NO313996B1 (no)	1994-09-19	1995-09-15	Krystallinsk solvat av forbindelsen 6-hydroksy-2-(4- hydroksyfenyl)-3-[4-(2-piperidinoetoksy)benzoyl]benzo[b]tiofenhydroklorid, fremgangsmåtefor fremstilling av solvatet, og fremgangsmåte for fremstilling av en ikke-solvatisert utgaveav forbind

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO19953658A NO313996B1 (no)	1994-09-19	1995-09-15	Krystallinsk solvat av forbindelsen 6-hydroksy-2-(4- hydroksyfenyl)-3-[4-(2-piperidinoetoksy)benzoyl]benzo[b]tiofenhydroklorid, fremgangsmåtefor fremstilling av solvatet, og fremgangsmåte for fremstilling av en ikke-solvatisert utgaveav forbind

Country Status (50)

Country	Link
US (4)	US6399778B1 (pt)
JP (2)	JP2860071B2 (pt)
KR (2)	KR100367376B1 (pt)
CN (2)	CN1068324C (pt)
AP (1)	AP754A (pt)
AT (2)	AT502957A1 (pt)
AU (3)	AU692907B2 (pt)
BE (2)	BE1009626A3 (pt)
BG (1)	BG62793B1 (pt)
BR (2)	BR9504060A (pt)
CA (2)	CA2158399C (pt)
CH (3)	CH691478A5 (pt)
CO (2)	CO4410191A1 (pt)
CZ (2)	CZ290343B6 (pt)
DE (3)	DE19549755B4 (pt)
DK (4)	DK175903B1 (pt)
EE (1)	EE03386B1 (pt)
EG (1)	EG23763A (pt)
ES (2)	ES2129293B1 (pt)
FI (2)	FI112226B (pt)
FR (2)	FR2732020B1 (pt)
GB (2)	GB2293382B (pt)
GE (1)	GEP19991821B (pt)
GR (2)	GR1002697B (pt)
HR (2)	HRP950483B1 (pt)
HU (2)	HU225417B1 (pt)
IE (2)	IE950722A1 (pt)
IL (3)	IL115314A (pt)
IS (1)	IS1788B (pt)
IT (2)	IT1277601B1 (pt)
LU (2)	LU88660A1 (pt)
LV (2)	LV11177B (pt)
MY (1)	MY116371A (pt)
NL (2)	NL1001196C2 (pt)
NO (2)	NO308107B1 (pt)
NZ (2)	NZ280027A (pt)
OA (1)	OA10406A (pt)
PE (2)	PE32796A1 (pt)
PL (2)	PL187686B1 (pt)
PT (2)	PT101770B (pt)
RO (2)	RO115260B1 (pt)
RS (2)	RS49578B (pt)
SE (2)	SE520721C2 (pt)
SI (2)	SI9500293A (pt)
SK (1)	SK283502B6 (pt)
TR (1)	TR199501136A2 (pt)
TW (1)	TW412534B (pt)
UA (2)	UA44240C2 (pt)
UY (1)	UY24040A1 (pt)
WO (1)	WO1996009045A1 (pt)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE39049E1 (en)	1992-07-28	2006-03-28	Eli Lilly And Company	Methods for inhibiting bone loss
USRE38968E1 (en)	1992-07-28	2006-02-07	Eli Lilly And Company	Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
TW366342B (en) *	1992-07-28	1999-08-11	Lilly Co Eli	The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5478847A (en)	1994-03-02	1995-12-26	Eli Lilly And Company	Methods of use for inhibiting bone loss and lowering serum cholesterol
CO4410191A1 (es) *	1994-09-19	1997-01-09	Lilly Co Eli	SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
US6458811B1 (en) *	1996-03-26	2002-10-01	Eli Lilly And Company	Benzothiophenes formulations containing same and methods
ATE464897T1 (de)	1996-03-26	2010-05-15	Lilly Co Eli	Benzothiophene und denen enthaltende zusammensetzungen
ZA979723B (en)	1996-10-30	1999-07-29	Lilly Co Eli	Methods of preventing breast cancer.
CA2236254A1 (en) *	1997-04-30	1998-10-30	David Warren Hoard	Process for preparing benzo¬b\|thiophenes
BR0010708A (pt)	1999-05-04	2002-02-19	Strakan Ltd	Glicosìdeos androgênicos e atividade androgênica dos mesmos
US6921827B2 (en) *	2000-11-27	2005-07-26	Eli Lilly And Company	Process for preparing 3-aryl-benzo{b} thiophenes
EP2316469A1 (en)	2002-02-22	2011-05-04	Shire LLC	Delivery system and methods for protecting and administering dextroamphetamine
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
WO2004029046A2 (en) *	2002-09-30	2004-04-08	A/S Gea Farmaceutisk Fabrik	Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
US6861422B2 (en)	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US20060106010A1 (en) *	2003-05-27	2006-05-18	Black Larry J	Methods for inhibiting bone loss
US7501426B2 (en)	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004029784A1 (de)	2004-06-21	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004030502A1 (de)	2004-06-24	2006-01-12	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
DE102004033670A1 (de)	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20060035903A1 (en)	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US20060058311A1 (en)	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
US7759485B2 (en)	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
US20060074088A1 (en)	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
US7728134B2 (en)	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
EP1630163A1 (de)	2004-08-25	2006-03-01	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
NZ553804A (en)	2004-09-29	2010-07-30	Bayer Schering Pharma Ag	Thermodynamically stable form of bay 43-9006 tosylate
US20060068010A1 (en) *	2004-09-30	2006-03-30	Stephen Turner	Method for improving the bioavailability of orally delivered therapeutics
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102004058337A1 (de)	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
DE102005035891A1 (de)	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US7439358B2 (en)	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
NZ573360A (en)	2006-05-04	2012-08-31	Boehringer Ingelheim Int	Polymorphic forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine
AR062927A1 (es)	2006-10-11	2008-12-17	Bayer Healthcare Ag	4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
US8344149B2 (en) *	2006-10-17	2013-01-01	Cipla Limited	Crystalline form of benzothiophene compound and process for preparation thereof
US8258291B2 (en) *	2006-10-25	2012-09-04	Mamtek International Limited	Process for the preparation of sucralose by the chlorination of sugar with triphosgene (BTC)
US20080103295A1 (en) *	2006-10-25	2008-05-01	David Losan Ho	Process for the preparation of sucrose-6-ester by esterification in the presence of solid superacid catalyst
DE102007032451B4 (de)	2007-07-12	2010-09-30	Icfs Gmbh	Verfahren zur Herstellung von aromatischen Ketonen
WO2009015004A1 (en) *	2007-07-20	2009-01-29	King Pharmaceuticals Research And Development, Inc.	Crystals of (2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl)(4-chlorophenyl)methanone
CA2695406A1 (en)	2007-08-03	2009-02-12	Boehringer Ingelheim International Gmbh	Crystalline form of a dihydropteridione derivative
CL2008003799A1 (es) *	2007-12-21	2009-12-18	Synthon Bv	Composicion farmaceutica que comprende raloxifeno en forma de tableta de liberacion inmediata; util para el tratamiento y/o prevencion de la osteoporosis.
PE20140960A1 (es)	2008-04-03	2014-08-15	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
WO2009150669A1 (en) *	2008-06-09	2009-12-17	Erregierre S.P.A.	Process for controlling the growth of a raloxifene hydrochloride crystal
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20200118243A (ko)	2008-08-06	2020-10-14	베링거 인겔하임 인터내셔날 게엠베하	메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
AU2009290911A1 (en)	2008-09-10	2010-03-18	Boehringer Ingelheim International Gmbh	Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
MX2011006713A (es)	2008-12-23	2011-07-13	Boehringer Ingelheim Int	Formas salinas de compuesto organico.
AR074990A1 (es)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
WO2011000581A2 (en)	2009-07-02	2011-01-06	Synthon B.V.	Raloxifene composition
EP2314581B1 (en)	2009-10-23	2012-07-25	Hexal AG	A process for preparing benzo[b]thiophene derivatives
AU2010323068B2 (en)	2009-11-27	2015-09-03	Boehringer Ingelheim International Gmbh	Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
WO2011099942A1 (en)	2010-02-09	2011-08-18	Silverstone Pharma	New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
KR101927068B1 (ko)	2010-05-05	2018-12-10	베링거 인겔하임 인터내셔날 게엠베하	체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
WO2011161161A1 (en)	2010-06-24	2011-12-29	Boehringer Ingelheim International Gmbh	Diabetes therapy
US8546566B2 (en)	2010-10-12	2013-10-01	Boehringer Ingelheim International Gmbh	Process for manufacturing dihydropteridinones and intermediates thereof
IT1403083B1 (it) *	2010-10-25	2013-10-04	Fidia Farmaceutici	Nuova forma polimorfa di raloxifene cloridrato
US9034883B2 (en)	2010-11-15	2015-05-19	Boehringer Ingelheim International Gmbh	Vasoprotective and cardioprotective antidiabetic therapy
US9358233B2 (en)	2010-11-29	2016-06-07	Boehringer Ingelheim International Gmbh	Method for treating acute myeloid leukemia
US9370535B2 (en)	2011-05-17	2016-06-21	Boehringer Ingelheim International Gmbh	Method for treatment of advanced solid tumors
WO2013010964A1 (en)	2011-07-15	2013-01-24	Boehringer Ingelheim International Gmbh	Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
EP2849754B1 (en)	2012-05-14	2022-09-14	Boehringer Ingelheim International GmbH	Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
EP2849755A1 (en)	2012-05-14	2015-03-25	Boehringer Ingelheim International GmbH	A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2014135834A1 (en)	2013-03-05	2014-09-12	Cipla House	Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
JP2016525532A (ja)	2013-07-26	2016-08-25	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	骨髄異形成症候群の処置
ES2950384T3 (es)	2014-02-28	2023-10-09	Boehringer Ingelheim Int	Uso médico de un inhibidor de DPP-4
US9867831B2 (en)	2014-10-01	2018-01-16	Boehringer Ingelheim International Gmbh	Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
CN104496963A (zh) *	2014-12-02	2015-04-08	千辉药业（安徽）有限责任公司	一种盐酸雷洛昔芬的制备方法
JP2019517542A (ja)	2016-06-10	2019-06-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	リナグリプチンおよびメトホルミンの組合せ
KR102815172B1 (ko) *	2020-02-25	2025-05-29	엘지전자 주식회사	히트펌프 및 그 동작방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3869485A (en) *	1969-09-25	1975-03-04	Allied Chem	Preparation of acid chlorides with phosgene in the presence of a catalyst
GB1456323A (en) *	1974-06-06	1976-11-24	Labaz	Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US4133814A (en)	1975-10-28	1979-01-09	Eli Lilly And Company	2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
IL65379A0 (en) *	1981-04-03	1982-05-31	Lilly Co Eli	Process for preparing acylated benzothiophenes
AU555658B2 (en)	1981-04-03	1986-10-02	Eli Lilly And Company	Benzothiophene compounds
IL65378A (en) *	1981-04-03	1986-02-28	Lilly Co Eli	Process for preparing 3-(4-aminoethoxybenzoyl)benzo-(b)thiophenes
US4418068A (en) *	1981-04-03	1983-11-29	Eli Lilly And Company	Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) *	1981-04-03	1983-04-19	Eli Lilly And Company	Synthesis of acylated benzothiophenes
ZA822247B (en)	1981-04-03	1983-11-30	Lilly Co Eli	Benzothiophene compounds and process for preparing them
US4358593A (en) *	1981-04-03	1982-11-09	Eli Lilly And Company	Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
DE4117512A1 (de) *	1991-05-25	1992-11-26	Schering Ag	2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
JP3157882B2 (ja) *	1991-11-15	2001-04-16	帝国臓器製薬株式会社	新規なベンゾチオフエン誘導体
US5169860A (en)	1992-03-13	1992-12-08	Eli Lilly And Company	Antitumor compositions and methods of treatment
TW383306B (en) *	1992-12-22	2000-03-01	Lilly Co Eli	New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
TW275584B (pt)	1993-06-24	1996-05-11	Fli Lilly And Co
US6756388B1 (en)	1993-10-12	2004-06-29	Pfizer Inc.	Benzothiophenes and related compounds as estrogen agonists
US5523416A (en)	1994-07-22	1996-06-04	Eli Lilly And Company	Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
CO4410191A1 (es) *	1994-09-19	1997-01-09	Lilly Co Eli	SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS

1995
- 1995-06-02 CO CO95023870A patent/CO4410191A1/es unknown
- 1995-06-02 CO CO95023869A patent/CO4410190A1/es unknown
- 1995-06-05 TW TW084105613A patent/TW412534B/zh not_active IP Right Cessation
- 1995-06-06 US US08/469,093 patent/US6399778B1/en not_active Expired - Fee Related
- 1995-06-06 US US08/469,961 patent/US6472531B1/en not_active Expired - Lifetime
- 1995-06-06 US US08/467,485 patent/US5731327A/en not_active Expired - Lifetime
- 1995-06-07 PE PE1995270673A patent/PE32796A1/es not_active IP Right Cessation
- 1995-06-07 PE PE1995270674A patent/PE14796A1/es not_active Application Discontinuation
- 1995-09-13 ES ES009501775A patent/ES2129293B1/es not_active Expired - Fee Related
- 1995-09-13 ES ES09501774A patent/ES2109882B1/es not_active Revoked
- 1995-09-14 UA UA95094168A patent/UA44240C2/uk unknown
- 1995-09-14 NL NL1001196A patent/NL1001196C2/nl active Search and Examination
- 1995-09-14 IL IL11531495A patent/IL115314A/xx not_active IP Right Cessation
- 1995-09-14 UA UA95094169A patent/UA42716C2/uk unknown
- 1995-09-14 IL IL12528395A patent/IL125283A/en not_active IP Right Cessation
- 1995-09-14 IL IL11531595A patent/IL115315A/xx not_active IP Right Cessation
- 1995-09-14 NL NL1001194A patent/NL1001194C2/nl active Search and Examination
- 1995-09-15 KR KR1019950030209A patent/KR100367376B1/ko not_active Expired - Lifetime
- 1995-09-15 CZ CZ19952403A patent/CZ290343B6/cs not_active IP Right Cessation
- 1995-09-15 DK DK199501027A patent/DK175903B1/da not_active IP Right Cessation
- 1995-09-15 IT IT95MI001935A patent/IT1277601B1/it active IP Right Grant
- 1995-09-15 SE SE9503213A patent/SE520721C2/sv not_active IP Right Cessation
- 1995-09-15 NO NO953657A patent/NO308107B1/no not_active IP Right Cessation
- 1995-09-15 KR KR1019950030210A patent/KR100381346B1/ko not_active Expired - Lifetime
- 1995-09-15 UY UY24040A patent/UY24040A1/es not_active IP Right Cessation
- 1995-09-15 NO NO19953658A patent/NO313996B1/no not_active IP Right Cessation
- 1995-09-15 CA CA002158399A patent/CA2158399C/en not_active Expired - Lifetime
- 1995-09-15 DK DK199501028A patent/DK175897B1/da not_active IP Right Cessation
- 1995-09-15 CZ CZ19952402A patent/CZ292007B6/cs not_active IP Right Cessation
- 1995-09-15 RO RO95-01620A patent/RO115260B1/ro unknown
- 1995-09-15 PT PT101770A patent/PT101770B/pt not_active IP Right Cessation
- 1995-09-15 RO RO95-01619A patent/RO115259B1/ro unknown
- 1995-09-15 PT PT101771A patent/PT101771B/pt not_active IP Right Cessation
- 1995-09-15 NZ NZ280027A patent/NZ280027A/en not_active IP Right Cessation
- 1995-09-15 IT IT95MI001936A patent/IT1277602B1/it active IP Right Grant
- 1995-09-15 SE SE9503214A patent/SE509265C2/sv not_active IP Right Cessation
- 1995-09-15 CA CA002158400A patent/CA2158400C/en not_active Expired - Lifetime
- 1995-09-15 NZ NZ280028A patent/NZ280028A/en not_active IP Right Cessation
- 1995-09-17 EG EG76395A patent/EG23763A/xx active
- 1995-09-18 JP JP7238211A patent/JP2860071B2/ja not_active Expired - Lifetime
- 1995-09-18 LU LU88660A patent/LU88660A1/fr unknown
- 1995-09-18 AT AT0154395A patent/AT502957A1/de not_active Application Discontinuation
- 1995-09-18 HR HR950483A patent/HRP950483B1/xx not_active IP Right Cessation
- 1995-09-18 FI FI954402A patent/FI112226B/fi not_active IP Right Cessation
- 1995-09-18 CH CH02628/95A patent/CH691478A5/de not_active IP Right Cessation
- 1995-09-18 GR GR950100340A patent/GR1002697B/el not_active IP Right Cessation
- 1995-09-18 HR HR950482A patent/HRP950482B1/xx not_active IP Right Cessation
- 1995-09-18 GR GR950100341A patent/GR1002709B/el not_active IP Right Cessation
- 1995-09-18 AU AU31731/95A patent/AU692907B2/en not_active Ceased
- 1995-09-18 AU AU31730/95A patent/AU691955B2/en not_active Expired
- 1995-09-18 CH CH02629/95A patent/CH691125A5/de not_active IP Right Cessation
- 1995-09-18 HU HU9502721A patent/HU225417B1/hu not_active IP Right Cessation
- 1995-09-18 BE BE9500761A patent/BE1009626A3/fr active
- 1995-09-18 FR FR9510922A patent/FR2732020B1/fr not_active Expired - Fee Related
- 1995-09-18 CN CN95118449A patent/CN1068324C/zh not_active Expired - Lifetime
- 1995-09-18 MY MYPI95002762A patent/MY116371A/en unknown
- 1995-09-18 BR BR9504060A patent/BR9504060A/pt not_active IP Right Cessation
- 1995-09-18 GB GB9519028A patent/GB2293382B/en not_active Expired - Fee Related
- 1995-09-18 CN CN95118629A patent/CN1075069C/zh not_active Expired - Lifetime
- 1995-09-18 SI SI9500293A patent/SI9500293A/sl not_active IP Right Cessation
- 1995-09-18 BR BR9504059A patent/BR9504059A/pt not_active IP Right Cessation
- 1995-09-18 FI FI954403A patent/FI121424B/fi not_active IP Right Cessation
- 1995-09-18 CH CH01780/00A patent/CH691594A5/de not_active IP Right Cessation
- 1995-09-18 LV LVP-95-284A patent/LV11177B/en unknown
- 1995-09-18 SI SI9500292A patent/SI9500292A/sl not_active IP Right Cessation
- 1995-09-18 FR FR9510921A patent/FR2724655B1/fr not_active Expired - Fee Related
- 1995-09-18 BE BE9500760A patent/BE1009625A3/fr active
- 1995-09-18 GB GB9519032A patent/GB2293602B/en not_active Expired - Fee Related
- 1995-09-18 AT AT0154295A patent/AT407988B/de not_active IP Right Cessation
- 1995-09-18 LU LU88661A patent/LU88661A1/fr unknown
- 1995-09-18 JP JP7238209A patent/JPH08193081A/ja active Pending
- 1995-09-18 HU HU9502723A patent/HU227683B1/hu not_active IP Right Cessation
- 1995-09-18 LV LVP-95-285A patent/LV11178B/en unknown
- 1995-09-19 AU AU37186/95A patent/AU3718695A/en not_active Abandoned
- 1995-09-19 DE DE19549755A patent/DE19549755B4/de not_active Expired - Fee Related
- 1995-09-19 RS YUP-613/95A patent/RS49578B/sr unknown
- 1995-09-19 PL PL95310517A patent/PL187686B1/pl not_active IP Right Cessation
- 1995-09-19 DE DE19534745A patent/DE19534745B4/de not_active Expired - Fee Related
- 1995-09-19 SK SK233-97A patent/SK283502B6/sk not_active IP Right Cessation
- 1995-09-19 TR TR95/01136A patent/TR199501136A2/xx unknown
- 1995-09-19 PL PL95310518A patent/PL182450B1/pl not_active IP Right Cessation
- 1995-09-19 IE IE950722A patent/IE950722A1/en not_active IP Right Cessation
- 1995-09-19 DE DE19534744A patent/DE19534744A1/de not_active Ceased
- 1995-09-19 WO PCT/US1995/011872 patent/WO1996009045A1/en not_active Ceased
- 1995-09-19 RS YU61495A patent/RS49513B/sr unknown
- 1995-09-19 IE IE950721A patent/IE80883B1/en not_active IP Right Cessation
- 1995-09-19 AP APAP/P/1997/000938A patent/AP754A/en active
- 1995-09-19 GE GEAP19953626A patent/GEP19991821B/en unknown
- 1995-09-19 EE EE9700055A patent/EE03386B1/xx unknown
1997
- 1997-01-09 DK DK199700027A patent/DK175887B1/da not_active IP Right Cessation
- 1997-01-09 DK DK199700028A patent/DK175886B1/da not_active IP Right Cessation
- 1997-02-18 BG BG101242A patent/BG62793B1/bg unknown
- 1997-03-18 IS IS4446A patent/IS1788B/is unknown
- 1997-03-19 OA OA60977A patent/OA10406A/en unknown
2002
- 2002-02-26 US US10/083,179 patent/US20020173645A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1127253A (zh)	1996-07-24
CH691478A5 (de)	2001-07-31
DK175887B1 (da)	2005-05-23
DE19549755B4 (de)	2005-05-04
AU3173095A (en)	1996-04-04
LV11177A (lv)	1996-04-20
IS1788B (is)	2001-11-28
PL182450B1 (pl)	2002-01-31
CZ240295A3 (en)	1996-04-17
RO115260B1 (ro)	1999-12-30
IS4446A (is)	1997-03-18
FR2724655A1 (fr)	1996-03-22
EE9700055A (et)	1997-08-15
ITMI951936A0 (it)	1995-09-15
DK102895A (da)	1996-03-20
DK175897B1 (da)	2005-05-30
NO953658D0 (no)	1995-09-15
ES2109882B1 (es)	1998-08-16
CH691125A5 (de)	2001-04-30
BG62793B1 (bg)	2000-08-31
NL1001196A1 (nl)	1996-03-19
LV11177B (en)	1996-08-20
FR2732020B1 (fr)	1997-11-14
LU88660A1 (fr)	1996-07-15
FI112226B (fi)	2003-11-14
ES2129293B1 (es)	2000-01-16
HRP950482A2 (en)	1998-02-28
AP754A (en)	1999-07-22
FR2724655B1 (fr)	1997-11-14
KR960010634A (ko)	1996-04-20
BR9504060A (pt)	1996-09-24
CA2158400C (en)	2006-10-24
HRP950483B1 (en)	2003-02-28
IE950722A1 (en)	1996-03-20
PL187686B1 (pl)	2004-09-30
SE509265C2 (sv)	1998-12-21
DK2797A (da)	1997-01-09
US5731327A (en)	1998-03-24
OA10406A (en)	2001-12-05
HRP950483A2 (en)	1997-10-31
FI121424B (fi)	2010-11-15
CZ290343B6 (cs)	2002-07-17
AU3718695A (en)	1996-04-09
CA2158399C (en)	2001-03-20
CN1075069C (zh)	2001-11-21
PL310518A1 (en)	1996-04-01
HUT74178A (en)	1996-11-28
MY116371A (en)	2004-01-31
BE1009626A3 (fr)	1997-06-03
CO4410191A1 (es)	1997-01-09
US6399778B1 (en)	2002-06-04
HU225417B1 (en)	2006-11-28
IL115315A0 (en)	1995-12-31
GB2293602B (en)	1998-05-06
SE9503213D0 (sv)	1995-09-15
IT1277601B1 (it)	1997-11-11
NZ280027A (en)	1997-05-26
FR2732020A1 (fr)	1996-09-27
IE950721A1 (en)	1996-03-20
HUT75033A (en)	1997-03-28
SI9500292A (en)	1996-06-30
NO953658L (no)	1996-03-20
CA2158399A1 (en)	1996-03-20
DK175886B1 (da)	2005-05-23
DK102795A (da)	1996-03-20
EG23763A (en)	2007-08-08
PE14796A1 (es)	1996-05-19
AU3173195A (en)	1996-04-04
WO1996009045A1 (en)	1996-03-28
TW412534B (en)	2000-11-21
AU691955B2 (en)	1998-05-28
RO115259B1 (ro)	1999-12-30
PT101770A (pt)	1996-04-30
CN1132205A (zh)	1996-10-02
FI954403A7 (fi)	1996-03-20
DK175903B1 (da)	2005-06-06
US6472531B1 (en)	2002-10-29
UY24040A1 (es)	1996-03-07
BR9504059A (pt)	1996-09-24
PT101771B (pt)	1997-04-30
GB2293602A (en)	1996-04-03
HRP950482B1 (en)	2007-04-30
HU9502721D0 (en)	1995-11-28
IL115314A0 (en)	1996-05-14
YU61495A (sh)	1998-05-15
JPH08193081A (ja)	1996-07-30
KR100381346B1 (ko)	2004-04-13
IT1277602B1 (it)	1997-11-11
SE9503214D0 (sv)	1995-09-15
DE19534745A1 (de)	1996-04-04
AT502957A1 (de)	2007-06-15
DE19534745B4 (de)	2004-06-09
NL1001194A1 (nl)	1996-03-19
IL115314A (en)	2000-02-29
FI954402L (fi)	1996-03-20
JP2860071B2 (ja)	1999-02-24
GB2293382B (en)	1998-08-19
IL125283A (en)	2001-06-14
NL1001194C2 (nl)	1997-04-04
DE19534744A1 (de)	1996-03-21
PT101770B (pt)	1997-04-30
RS49513B (sr)	2006-10-27
LV11178A (lv)	1996-04-20
RS49578B (sr)	2007-04-10
NO953657D0 (no)	1995-09-15
LU88661A1 (fr)	1996-07-15
ATA154295A (de)	2000-12-15
GB2293382A (en)	1996-03-27
CN1068324C (zh)	2001-07-11
IL115315A (en)	1999-09-22
BG101242A (en)	1998-03-31
GEP19991821B (en)	1999-11-05
GB9519032D0 (en)	1995-11-15
KR100367376B1 (ko)	2003-03-06
ITMI951936A1 (it)	1997-03-15
TR199501136A2 (tr)	1996-06-21
JPH08176147A (ja)	1996-07-09
CH691594A5 (de)	2001-08-31
SI9500293A (en)	1996-06-30
BE1009625A3 (fr)	1997-06-03
AP9700938A0 (en)	1997-04-30
CZ240395A3 (en)	1996-04-17
HU227683B1 (en)	2011-11-28
HU9502723D0 (en)	1995-11-28
FI954402A0 (fi)	1995-09-18
US20020173645A1 (en)	2002-11-21
FI954403A0 (fi)	1995-09-18
EE03386B1 (et)	2001-04-16
PL310517A1 (en)	1996-04-01
NO313996B1 (no)	2003-01-13
UA44240C2 (uk)	2002-02-15
CA2158400A1 (en)	1996-03-20
NO953657L (no)	1996-03-20
PT101771A (pt)	1996-04-30
IE80883B1 (en)	1999-05-19
CO4410190A1 (es)	1997-01-09
UA42716C2 (uk)	2001-11-15
NL1001196C2 (nl)	1997-04-04
AT407988B (de)	2001-07-25
DK2897A (da)	1997-01-09
ITMI951935A0 (it)	1995-09-15
GR1002709B (el)	1997-06-04
CZ292007B6 (cs)	2003-07-16
NZ280028A (en)	1997-05-26
GB9519028D0 (en)	1995-11-15
SE9503214L (sv)	1996-03-20
SK283502B6 (sk)	2003-08-05
KR960010637A (ko)	1996-04-20
SE520721C2 (sv)	2003-08-12
ES2109882A1 (es)	1998-01-16
ITMI951935A1 (it)	1997-03-15
SE9503213L (sv)	1996-03-20
LV11178B (en)	1996-08-20
SK23397A3 (en)	1997-08-06
YU61395A (sh)	1998-09-18
GR1002697B (el)	1997-05-22
PE32796A1 (es)	1996-08-07
ES2129293A1 (es)	1999-06-01
HK1019009A1 (en)	2000-01-14
AU692907B2 (en)	1998-06-18

Publication	Publication Date	Title
NO308107B1 (no)	2000-07-24	Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel
AR027162A1 (es)	2003-03-19	Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
NO306725B1 (no)	1999-12-13	Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler
NO305903B1 (no)	1999-08-16	Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
HUP9902092A3 (en)	2000-12-28	Metalloproteinase inhibitor benzenesulfonamide derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
IL135176A0 (en)	2001-05-20	Benzothiazole derivatives and pharmaceutical compositions containing the same
HUP9901159A3 (en)	2000-05-29	Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
NO903925D0 (no)	1990-09-10	Fremgangsmaate for fremstilling av 3-(1-substituert-4-piperazinyl)-1h-indazoler samt anvendelse som legemidler.
NO20040145L (no)	1999-06-25	Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
DE69528769D1 (de)	2002-12-12	Aerosolformulierung für arzneimittel enthaltend polyglycolisierte glyzeride
IL133097A0 (en)	2001-03-19	Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
NO964639L (no)	1997-05-05	Substituerte sulfonimidamider, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
ZA962916B (en)	1996-10-14	New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
NO305906B1 (no)	1999-08-16	Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
IL134536A0 (en)	2001-04-30	Compounds possessing neuronal activity and pharmaceutical compositions containing the same
BR9610821A (pt)	1999-07-13	Derivado de aminoácido uso de um composto e medicamento contendo o mesmo
NO953367L (no)	1996-03-01	Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
IL117620A0 (en)	1996-07-23	Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
NO20006646D0 (no)	2000-12-22	Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
HUP0100853A3 (en)	2003-01-28	Nitrate salt of anti-ulcer medicine and pharmaceutical compositions containing the same compounds
NO306113B1 (no)	1999-09-20	Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
NO306347B1 (no)	1999-10-25	Eleutherobin og analoger av denne, anvendelse av forbindelsen samt farmasöytisk preparat inneholdende denne
DK378988A (da)	1989-01-10	Dopamin-beta-hydroxylaseinhibitorer, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse forbindelser
NO308527B1 (no)	2000-09-25	Substituerte 2-naftoylguanidiner, deres anvendelse for fremstilling av et medikament samt legemidler og preparater inneholdende forbindelsene
NO960364L (no)	1996-07-31	Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen

Legal Events

Date	Code	Title	Description
2015-04-27	MM1K	Lapsed by not paying the annual fees